How to Detect

In 5 simple steps


Self-collect your sample


Prepare your sample


Mix the sample with our proprietary reagent bead


Use the reusable Detect Hub™ to process sample in 55 min


Read results in 10 min

Why Detect

Clinically studied and validated

Shown to be on par with expensive PCR lab tests in FDA-reviewed clinical studies.



Across our clinical studies, our test is comparable to PCR tests.



We correctly identified positive samples 90.9% of the time in clinical studies.



We correctly identified negative samples 100% of the time in clinical studies.

<1 copy/µL

Limit of Detection

Our Limit of Detection is 313 copies/swab (<1 copy/µL) in analytical studies, which is on par with widely used PCR lab tests.

A clinical study was conducted across two sites, with testing performed by untrained operators. The study enrolled symptomatic subjects and subjects with recent Covid-19 exposure, each of whom self-collected two nasal swab samples (adults) or had two nasal swab samples collected by an adult caregiver (children under 14). For each subject, one swab was collected and sent to a reference laboratory and tested using a high sensitivity FDA-authorized SARS-CoV-2 RT-PCR test by trained laboratory personnel as a comparator, while the other swab was tested using the Detect Covid-19 Test™ by the untrained subject or caregiver at the clinical site. Comparing the Detect Covid-19 Test™’s results to those produced by the high sensitivity FDA-authorized SARS-CoV-2 RT-PCR test, the Positive Percent Agreement (PPA) was 90.9% (30/33) and the Negative Percent Agreement (NPA) was 100% (79/79) with expert interpretation.

How it works

Why a molecular test?

Detect™ conducted an analysis of our test's performance compared to other at-home rapid tests on the market, and we found that the Detect™ Covid-19 Test is 53x more sensitive than the leading at-home rapid antigen test.1

Superior sensitivity means that Detect™ can identify an infection earlier than antigen tests. This helps ensure that you get antiviral medications as quickly as possible, when they are most effective, and enables you to isolate immediately, avoiding transmission to your family and friends.

1Based on comparative analysis of Limit of Detection (LoD) metrics between the Detect™ Covid-19 Test and current FDA authorized over-the-counter rapid antigen tests

Graphic showing how Detect compares

The future of testing is in the home

Detect is developing home test products for a range of other diseases, from STIs to Strep Throat. Join us to invent the future of diagnostics.

Join Us